Denysyk (pictured) was formerly a consultant for Pharmaceutical Intelligence. Before that he was an analytics and strategy director for Roche Pharmaceuticals and strategic marketing research director for Pfizer Pharmaceuticals. Earlier in his career he worked for Sanofi-Aventis and Novartis.

HRA parent company MJH & Associates said it was “very fortunate to welcome Oleh as president of HRA, as he brings a distinguished career and leadership in our industry”.

Maglione, Denysyk’s predecessor, has been with HRA for less than two years. MJH’s chief operating officer Tighe Blazier said: “We acknowledge John for his service to HRA and look forward to his continued contribution to our company.”